- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-GPR20 monoclonal antibody
Anti-GPR20 antibody for FACS & in-vivo assay
Go to GPR20/GPR20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T65429-Ab-1/ GM-Tg-hg-T65429-Ab-2 | Anti-Human GPR20 monoclonal antibody | Human |
| GM-Tg-rg-T65429-Ab-1/ GM-Tg-rg-T65429-Ab-2 | Anti-Rat GPR20 monoclonal antibody | Rat |
| GM-Tg-mg-T65429-Ab-1/ GM-Tg-mg-T65429-Ab-2 | Anti-Mouse GPR20 monoclonal antibody | Mouse |
| GM-Tg-cynog-T65429-Ab-1/ GM-Tg-cynog-T65429-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GPR20 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T65429-Ab-1/ GM-Tg-felg-T65429-Ab-2 | Anti-Feline GPR20 monoclonal antibody | Feline |
| GM-Tg-cang-T65429-Ab-1/ GM-Tg-cang-T65429-Ab-2 | Anti-Canine GPR20 monoclonal antibody | Canine |
| GM-Tg-bovg-T65429-Ab-1/ GM-Tg-bovg-T65429-Ab-2 | Anti-Bovine GPR20 monoclonal antibody | Bovine |
| GM-Tg-equg-T65429-Ab-1/ GM-Tg-equg-T65429-Ab-2 | Anti-Equine GPR20 monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-T65429-Ab-1/ GM-Tg-hg-T65429-Ab-2; GM-Tg-rg-T65429-Ab-1/ GM-Tg-rg-T65429-Ab-2; GM-Tg-mg-T65429-Ab-1/ GM-Tg-mg-T65429-Ab-2; GM-Tg-cynog-T65429-Ab-1/ GM-Tg-cynog-T65429-Ab-2; GM-Tg-felg-T65429-Ab-1/ GM-Tg-felg-T65429-Ab-2; GM-Tg-cang-T65429-Ab-1/ GM-Tg-cang-T65429-Ab-2; GM-Tg-bovg-T65429-Ab-1/ GM-Tg-bovg-T65429-Ab-2; GM-Tg-equg-T65429-Ab-1/ GM-Tg-equg-T65429-Ab-2 |
| Products Name | Anti-GPR20 monoclonal antibody |
| Format | mab |
| Target Name | GPR20 |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-GPR20 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | Products Developing | Multi-species GPR20 VLP (virus-like particle) (Products Developing) |
| ORF Viral Vector | pGMLP003584 | human GPR20 Lentivirus plasmid |
| ORF Viral Vector | vGMLP003584 | human GPR20 Lentivirus particle |
| ORF Viral Vector | pGMLPm003864 | mouse Gpr20 Lentivirus plasmid |
| ORF Viral Vector | vGMLPm003864 | mouse Gpr20 Lentivirus particle |
Target information
| Target ID | GM-T65429 |
| Target Name | GPR20 |
| Gene ID | 2843,239530,60667,693582,482061,109496266,515695,100069651 |
| Gene Symbol and Synonyms | A430106B11Rik,Gpcr5-1,GPR20,P2Y4 |
| Uniprot Accession | Q99678 |
| Uniprot Entry Name | GPR20_HUMAN |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | N/A |
| Gene Ensembl | ENSG00000204882 |
| Target Classification | GPCR |
The target: GPR20, gene name: GPR20, also named as . Enables G protein-coupled receptor activity. Predicted to be involved in positive regulation of Rho protein signal transduction and positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway. Located in cytosol and plasma membrane. Is integral component of plasma membrane. Part of receptor complex..
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
